Understanding the Drivers of CAB PrEP Uptake and Use among Women in sub-Saharan Africa to Build Demand for New PrEP Methods
Casey Bishopp, Zoe Mungai-Barris, Elmari Briedenhann, Emily Donaldson, Elizabeth Irungu, Katie Schwartz · 2024
Read Understanding the Drivers of CAB PrEP Uptake and Use among Women in sub-Saharan Africa to Build Demand for New PrEP Methods by Casey Bishopp, Zoe Mungai-Barris, Elmari Briedenhann, Emily Donaldson, Elizabeth Irungu, Katie Schwartz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11625055.txt.
Description
Casey Bishopp and co-authors review what drives women in sub-Saharan Africa to use a long-acting HIV prevention shot. Their 2024 paper covers cabotegravir, given by injection before exposure to the virus. As the shot rolls out, knowing why women choose or avoid it matters. The review sums up recent findings on those drivers.
Past comfort with injections and trust in the shot's strength helped uptake. Fear of needles hurt it, as did negative views from people around the user. Leaders and users stay hopeful that the long-acting method will be popular. Still, gaps in knowledge remain. The authors say these drivers should shape outreach and choice support as more methods join the market.
Catalog record
| CREATOR | Casey Bishopp, Zoe Mungai-Barris, Elmari Briedenhann, Emily Donaldson, Elizabeth Irungu, Katie Schwartz |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |